Comment on _The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development_

Aidan Hollis

PharmacoEconomics, 2005, vol. 23, issue 12, pages 1187-1192

Keywords: Drug-classes; Health-policy; Regulatory-process (search for similar items in EconPapers)
JEL-codes: C D I Z I1 I19 I18 I11 (search for similar items in EconPapers)
Date: 2005

Downloads: (external link)
http://pharmacoeconomics.adisonline.com/pt/re/phe/ ... -200523120-00002.pdf (application/pdf)
http://pharmacoeconomics.adisonline.com/pt/re/phe/ ... -200523120-00002.htm (text/html)
Pay per view

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:wkh:phecon:v:23:y:2005:i:12:p:1187-1192

Access Statistics for this article

PharmacoEconomics is edited by Christopher I. Carswell, MSc, MRPharmS

More articles in PharmacoEconomics from Wolters Kluwer Health | Adis
Series data maintained by Remco Bouckaert ().